CAS 2095625-97-9

Milademetan tosylate hydrate

CAS : 2095625-97-9

Milademetan tosylate hydrate, an oral MDM2 inhibitor targeting AML and solid tumors, induces G1 arrest and apoptosis.

Formule : C₃₇H₄₄Cl₂FN₅O₈S

Couleur et forme : Solid

Masse moléculaire : 808.74

Ref: TM-T73634

Milademetan tosylate

CAS : 2095625-97-9

Milademetan tosylate is an investigational anticancer agent, which is a small molecule inhibitor derived from synthetic chemical sources. It functions as a selective antagonist targeting the murine double minute 2 (MDM2) oncoprotein, thereby disrupting its interaction with the tumor suppressor protein p53. This mode of action prevents the degradation of p53, leading to the reactivation of its tumor suppressive functions, including cell cycle arrest and apoptosis in cancer cells harboring wild-type p53.

Formule : C₃₇H₄₂Cl₂FN₅O₇S

Degré de pureté : Min. 95%

Masse moléculaire : 790.7 g/mol

Ref: 3D-VID62597